BioMarin, as an extremely successful multinational commercial biopharmaceutical company, provides important therapeutic treatments to hundreds of patients around the world who might otherwise go untreated. With patients spread across four continents, the global business, sales and customer support data from the United States, Europe, Latin America and the Middle East must be integrated and the information readily available to management for efficient business operations. Customers must be continually and consistently serviced by the BioMarin sales and customer service teams. Dave Wertzberger, Senior Director of Sales Operations for BioMarin, is charged with assuring these operations run smoothly and data is available to the diverse teams within BioMarin as well as to BioMarin management for analysis and reporting.
Multinational biopharmaceutical firm, BioMarin, faced multiple IT challenges when the company contacted Sesame Software. With business critical data spread across offices in the United States, the United Kingdom, Hong Kong, Argentina, Brazil and Colombia, BioMarin needed to:
- Create a warehouse for their sales and marketing data.
- Maintain and enhance the data in Salesforce by leveraging data from other systems and sources using practical data warehouse and ETL technologies.
Efficiency of analysis and reporting is important to corporate operations.
The BioMarin IT team selected Sesame Software’s Relational Junction for Salesforce and Relational Junction ETL Manager because they are cost-effective, short-time-to-implement yet feature-rich data protection and integration solutions.
- Provides Salesforce data backup.
- Integrates disparate data repositories for coherent reporting for sales and marketing.
- Delivers consistent, integrated view of their customers to sales, marketing and customer service.
- Supplies key business automation and scheduling to reduce manual data analysis processes.
- Efficiently allows bidirectional integration of Salesforce CRM data with proprietary business information database, oracle ERP system and case management database for customer support.
- Cost-effective and straightforward to implement.
- Well-suited to BioMarin’s distributed multinational operational structure.
The Relational Junction for Salesforce bidirectional data integration features have significantly enhanced BioMarin’s Salesforce usage and transformed their data management processes by eliminating redundant reporting and time-intensive, manual information capture.
BioMarin has been using Relational Junction for Salesforce for three years to automatically integrate information across departmental databases providing the sales, customer service and management teams with comprehensive and consistent information to fuel BioMarin’s business operations.
Sesame Software simply works and we are 100% satisfied. Relational Junction has exceeded our expectations – I recommend it.
Dave Wertzberger, Senior Director of Sales Operations BioMarin
Dave explains, “We require an integrated business, sales and customer service data warehouse to do data analytics and reporting using Crystal Reports. We also need to capture select information from the warehouse to push back into Salesforce in order to optimize efficiency of sales territory management and customer support.”
Initially, the company tried using Salesforce’s built-in features. However, the feature set was extremely limited and did not provide an automated data integration and backup solution.
BioMarin is a multinational bio- pharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
The company’s product portfolio comprises four marketed products and multiple clinical and pre-clinical product candidates. Marketed products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (currently approved in the EU only) (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6- sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU.